Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanoparticle Delivery Systems in the Treatment of Diabetes Complications
Eliana B. Souto, Selma B. Souto, Joana R. Campos, et al.
Molecules (2019) Vol. 24, Iss. 23, pp. 4209-4209
Open Access | Times Cited: 170

Showing 1-25 of 170 citing articles:

Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology
Aleksandra Zielińska, Filipa Carreiró, Ana M. Oliveira, et al.
Molecules (2020) Vol. 25, Iss. 16, pp. 3731-3731
Open Access | Times Cited: 1071
Type II diabetes mellitus: a review on recent drug based therapeutics
Santwana Padhi, Amit Kumar Nayak, Anindita Behera
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110708-110708
Open Access | Times Cited: 511
Fruits and fruit by-products as sources of bioactive compounds. Benefits and trends of lactic acid fermentation in the development of novel fruit-based functional beverages
Luciana G. Ruiz Rodríguez, Víctor Manuel Zamora-Gasga, Micaela Pescuma, et al.
Food Research International (2020) Vol. 140, pp. 109854-109854
Closed Access | Times Cited: 220
Microemulsions and Nanoemulsions in Skin Drug Delivery
Eliana B. Souto, Amanda Cano, Carlos Martins‐Gomes, et al.
Bioengineering (2022) Vol. 9, Iss. 4, pp. 158-158
Open Access | Times Cited: 177
Diabetes mellitus and diabetic foot ulcer: Etiology, biochemical and molecular based treatment strategies via gene and nanotherapy
Arokia Vijaya Anand Mariadoss, Allur Subramaniyan Sivakumar, Chang‐Hun Lee, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113134-113134
Open Access | Times Cited: 81
Biogenic Selenium Nanoparticles in Biomedical Sciences: Properties, Current Trends, Novel Opportunities and Emerging Challenges in Theranostic Nanomedicine
Marjorie C. Zambonino, Ernesto Mateo Quizhpe, Lynda Mouheb, et al.
Nanomaterials (2023) Vol. 13, Iss. 3, pp. 424-424
Open Access | Times Cited: 66
Chitosan: An Overview of Its Properties, Solubility, Functional Technologies, Food and Health Applications.
Great Iruoghene Edo, Winifred Ndudi, Ali B. M. Ali, et al.
Carbohydrate Research (2025) Vol. 550, pp. 109409-109409
Closed Access | Times Cited: 4
Nanopharmaceutics: Part I—Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU
Eliana B. Souto, Gabriela F. Silva, João Dias-Ferreira, et al.
Pharmaceutics (2020) Vol. 12, Iss. 2, pp. 146-146
Open Access | Times Cited: 91
Theranostic nanoparticles with disease-specific administration strategies
Peisen Zhang, Yingying Li, Wen Tang, et al.
Nano Today (2021) Vol. 42, pp. 101335-101335
Closed Access | Times Cited: 86
Drug Delivery System in the Treatment of Diabetes Mellitus
Ruichen Zhao, Zhiguo Lü, Jun Yang, et al.
Frontiers in Bioengineering and Biotechnology (2020) Vol. 8
Open Access | Times Cited: 82
Sucupira Oil-Loaded Nanostructured Lipid Carriers (NLC): Lipid Screening, Factorial Design, Release Profile, and Cytotoxicity
Raquel Vieira, Patrícia Severino, Luciana Nalone, et al.
Molecules (2020) Vol. 25, Iss. 3, pp. 685-685
Open Access | Times Cited: 80
Biological efficacy of zinc oxide nanoparticles against diabetes: a preliminary study conducted in mice
Shafayet Ahmed Siddiqui, Md. Mamun Or Rashid, Md. Giash Uddin, et al.
Bioscience Reports (2020) Vol. 40, Iss. 4
Open Access | Times Cited: 73
Potential and Applications of Nanocarriers for Efficient Delivery of Biopharmaceuticals
Alam Zeb, Isra Rana, Ho-Ik Choi, et al.
Pharmaceutics (2020) Vol. 12, Iss. 12, pp. 1184-1184
Open Access | Times Cited: 72
In vivo oral insulin delivery via covalent organic frameworks
Farah Benyettou, Nawel Kaddour, Thirumurugan Prakasam, et al.
Chemical Science (2021) Vol. 12, Iss. 17, pp. 6037-6047
Open Access | Times Cited: 57
Natural Polysaccharide-Based Nanodrug Delivery Systems for Treatment of Diabetes
Aijun Qiu, Yunyun Wang, Genlin Zhang, et al.
Polymers (2022) Vol. 14, Iss. 15, pp. 3217-3217
Open Access | Times Cited: 55
Progress in Understanding Metabolic Syndrome and Knowledge of Its Complex Pathophysiology
Birendra Kumar Jha, Mingma Sherpa, Mohammad Imran, et al.
Diabetology (2023) Vol. 4, Iss. 2, pp. 134-159
Open Access | Times Cited: 39
Oral peptide therapeutics for diabetes treatment: State-of-the-art and future perspectives
Bingwen Ding, Zhu Zhu, Cong Guo, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 2006-2025
Open Access | Times Cited: 9
Diabetes: a review of its pathophysiology, and advanced methods of mitigation
Sarika Gupta, Nitin Sharma, Sandeep Arora, et al.
Current Medical Research and Opinion (2024) Vol. 40, Iss. 5, pp. 773-780
Closed Access | Times Cited: 8
In vitro and in silico investigation of glycyrrhizic acid encapsulated zein nanoparticles: A synergistic targeted drug delivery approach for breast cancer
Amit Kumar Srivastav, Pradeep Kumar Rajput, Jyoti Jaiswal, et al.
International Journal of Biological Macromolecules (2024) Vol. 266, pp. 131368-131368
Closed Access | Times Cited: 8
Nanopharmaceutics: Part II—Production Scales and Clinically Compliant Production Methods
Eliana B. Souto, Gabriela F. Silva, João Dias-Ferreira, et al.
Nanomaterials (2020) Vol. 10, Iss. 3, pp. 455-455
Open Access | Times Cited: 64
Natural products in diabetes research: quantitative literature analysis
Andy Wai Kan Yeung, Nikolay Tzvetkov, Alessandra Durazzo, et al.
Natural Product Research (2020) Vol. 35, Iss. 24, pp. 5813-5827
Open Access | Times Cited: 60
<p>Oral Nano Drug Delivery Systems for the Treatment of Type 2 Diabetes Mellitus: An Available Administration Strategy for Antidiabetic Phytocompounds</p>
Xin Nie, Zhejie Chen, Lan Pang, et al.
International Journal of Nanomedicine (2020) Vol. Volume 15, pp. 10215-10240
Open Access | Times Cited: 59
Polysaccharide-Based Nanoparticles for Colon-Targeted Drug Delivery Systems
Yubia De Anda-Flores, Elizabeth Carvajal‐Millán, Alma C. Campa-Mada, et al.
Polysaccharides (2021) Vol. 2, Iss. 3, pp. 626-647
Open Access | Times Cited: 50
Multi-functional self-assembly nanoparticles originating from small molecule natural product for oral insulin delivery through modulating tight junctions
Xiaohui Jia, Zhihua Yuan, Yuqin Yang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 32
Emerging trends in nano-based antidiabetic therapeutics: a path to effective diabetes management
Ritika Sharma, Shikha Jyoti Borah, Bhawna Verma, et al.
Materials Advances (2023) Vol. 4, Iss. 15, pp. 3091-3113
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top